Skin Cream Patent Claims Against Immudyne Tossed
The controversy dates back to 1996, when Immudyne and inventor Byron Donzis entered into a settlement agreement affirming various patent licenses between the parties related to a yeast-derived compound called glucan used in anti-wrinkling and sun protection skin cream. Following the settlement agreement, Donzis received several more glucan-related patents.
In 1999, Immudyne sued Donzis in...
To view the full article, register now.